Blaine Gabriel Fritz

Blaine Gabriel Fritz

Auto-generated profile, based on publicly available information

Blaine Gabriel Fritz

Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2020 in mBio
Verified
Journal Article
Open access
PDF file
LBLene Bay
Lene Bay
CBChristopher Barnes
Christopher Barnes
BFBlaine Gabriel Fritz
Blaine Gabriel Fritz
JTJonathan Thorsen
Jonathan Thorsen
MRMarlene Elise Møller Restrup
Marlene Elise Møller Restrup
TBThomas Bjarnsholt
Thomas Bjarnsholt
Human skin microbiota is thought to be unique according to the individual's lifestyle and genetic predisposition. This is true for the epidermal microbiota, while our findings demonstrate that the dermal microbiota is universal between healthy individuals. The preserved dermal microbial community is compositionally unique and functionally distinct to the specific environment in the depth of human skin. It is expected to have direct contact with the immune response of the human host, and research in the communication between host and microbiota should be targeted to this cutaneous compartment. This novel insight into specific microbial adaptation can be used advantageously in the research of chronic disorders and infections of the skin. It can enlighten the alteration between health and disease to the benefit of patients suffering from long-lasting socioeconomic illnesses.

9 July 2021 in npj Biofilms and Microbiomes
Verified
Journal Article
Open access
PDF file
JAJens Bo Andersen
Jens Bo Andersen
LHLouise Dahl Hultqvist
Louise Dahl Hultqvist
CJCharlotte Uldahl Jansen
Charlotte Uldahl Jansen
TJTim Holm Jakobsen
Tim Holm Jakobsen
MNMartin Nilsson
Martin Nilsson
Tim Tolker-NielsenTim Tolker-Nielsen
Tim Tolker-Nielsen
Microbial biofilms are involved in a number of infections that cannot be cured, as microbes in biofilms resist host immune defenses and antibiotic therapies. With no strict biofilm-antibiotic in the current pipelines, there is an unmet need for drug candidates that enable the current antibiotics to eradicate bacteria in biofilms. We used high-throughput screening to identify chemical compounds that reduce the intracellular c-di-GMP content in Pseudomonas aeruginosa. This led to the identification of a small molecule that efficiently depletes P. aeruginosa for c-di-GMP, inhibits biofilm formation, and disperses established biofilm. A combination of our lead compound with standard of care antibiotics showed improved eradication of an implant-associated infection established in mice. Genetic analyses provided evidence that the anti-biofilm compound stimulates the activity of the c-di-GMP phosphodiesterase BifA in P. aeruginosa. Our work constitutes a proof of concept for c-di-GMP phosphodiesterase-activating drugs administered in combination with antibiotics as a viable treatment strategy for otherwise recalcitrant infections.

2 September 2020 in Medical Microbiology and Immunology
Verified
Journal Article
Open access
PDF file
MAMaria Alhede
Maria Alhede
MLMelanie Lorenz
Melanie Lorenz
BFBlaine Gabriel Fritz
Blaine Gabriel Fritz
PJPeter Østrup Jensen
Peter Østrup Jensen
HRHans Christian Ring
Hans Christian Ring
TBThomas Bjarnsholt
Thomas Bjarnsholt
The ability of bacteria to aggregate and form biofilms impairs phagocytosis by polymorphonuclear leukocytes (PMNs). The aim of this study was to examine if the size of aggregates is critical for successful phagocytosis and how bacterial biofilms evade phagocytosis. We investigated the live interaction between PMNs andPseudomonas aeruginosa,Staphylococcus aureus,Escherichia coliandStaphylococcus epidermidisusing confocal scanning laser microscopy. Aggregate size significantly affected phagocytosis outcome and larger aggregates were less likely to be phagocytized. Aggregates ofS. epidermidiswere also less likely to be phagocytized than equally-sized aggregates of the other three species. We found that only aggregates of approx. 5 μm diameter or smaller were consistently phagocytosed. We demonstrate that planktonic and aggregated cells of all four species significantly reduced the viability of PMNs after 4 h of incubation. Our results indicate that larger bacterial aggregates are less likely to be phagocytosed by PMNs and we propose that, if the aggregates become too large, circulating PMNs may not be able to phagocytose them quickly enough, which may lead to chronic infection.

1 March 2019 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
KJK. Johani
K. Johani
BFB.G. Fritz
B.G. Fritz
TBThomas Bjarnsholt
Thomas Bjarnsholt
BLB.A. Lipsky
B.A. Lipsky
SJSlade O. Jensen
Slade O. Jensen
MMMatthew Malone
Matthew Malone


10 May 2024 in Gut Microbes
Verified
Journal Article
Open access
Lasse Andersson KvichLasse Andersson Kvich
Lasse Andersson Kvich
BFBlaine Gabriel Fritz
Blaine Gabriel Fritz
HZHenrike Zschach
Henrike Zschach
TTThilde Terkelsen
Thilde Terkelsen
HRHans Henrik Raskov
Hans Henrik Raskov
TBThomas Bjarnsholt
Thomas Bjarnsholt
Extensive research has explored the role of gut microbiota in colorectal cancer (CRC). Nonetheless, metatranscriptomic studies investigating the in situ functional implications of host-microbe interactions in CRC are scarce. Therefore, we characterized the influence of CRC core pathogens and biofilms on the tumor microenvironment (TME) in 40 CRC, paired normal, and healthy tissue biopsies using fluorescence in situ hybridization (FISH) and dual-RNA sequencing. FISH revealed that Fusobacterium spp. was associated with increased bacterial biomass and inflammatory response in CRC samples. Dual-RNA sequencing demonstrated increased expression of pro-inflammatory cytokines, defensins, matrix-metalloproteases, and immunomodulatory factors in CRC samples with high bacterial activity. In addition, bacterial activity correlated with the infiltration of several immune cell subtypes, including M2 macrophages and regulatory T-cells in CRC samples. Specifically, Bacteroides fragilis and Fusobacterium nucleatum correlated with the infiltration of neutrophils and CD4+ T-cells, respectively. The collective bacterial activity/biomass appeared to exert a more significant influence on the TME than core pathogens, underscoring the intricate interplay between gut microbiota and CRC. These results emphasize how biofilms and core pathogens shape the immune phenotype and TME in CRC while highlighting the need to extend the bacterial scope beyond CRC pathogens to advance our understanding and identify treatment targets.